🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Pharma Diagnostics & Analytics

Benchmark revenue and EBITDA valuation multiples for public comps like Bio-Techne, Sepax Technologies, Oxford Nanopore Techs, Proteomics International and Bioventix.

Pharma Diagnostics & Analytics

See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
Company EV EV/LTM Revenue EV/LTM EBITDA
$10.1B n/a n/a
$8.4B 6.9x 19.9x
$1.7B 8.4x -27.2x
$1.5B 5.4x -10.2x
$928M n/a n/a
$186M 10.1x 13.2x
$183M 2457.5x -5.3x
$168M n/a n/a
$46.5M 2.8x 13.8x
$39.0M 15.5x -9.6x
$21.5M n/a n/a
$20.0M 15.3x -9.1x
$6.0M n/a n/a
-$9.1M n/a 0.1x
-$24.2M -0.9x n/a

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.